SEARCH

SEARCH BY CITATION

References

  • 1
    Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127: 158991.
  • 2
    Soykan I, Sivri B, Sarosiek I, Kiernan B, McCallum RW. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci 1998; 43: 2398404.
  • 3
    Stanghellini V, Tosetti C, Paternico A et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996; 110: 103642.
  • 4
    Datz FL, Christian PE, Moore J. Gender-related differences in gastric emptying. J Nucl Med 1987; 28: 12047.
  • 5
    Horowitz M, Harding PE, Maddox AF et al. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1989; 32: 1519.
  • 6
    Horowitz M, Harding PE, Maddox AF et al. Gastric and oesophageal emptying in insulin-dependent diabetes mellitus. J Gastroenterol Hepatol 1986; 1: 97113.
  • 7
    Maleki D, Locke GR III, Camilleri M et al. Gastrointestinal symptoms among persons with diabetes in the community. Archives Intern Med 2000; 160: 280816.
  • 8
    Jung HK, Choung RS, Locke GR III et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology 2009; 136: 122533.
  • 9
    Jones KL, Russo A, Berry MK, Stevens JE, Wishart JM, Horowitz M. A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus. Am J Med 2002; 113: 44955.
  • 10
    Talley NJ, Young L, Bytzer P et al. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol 2001; 96: 716.
    Direct Link:
  • 11
    Bharucha AE, Camilleri M, Forstrom L, Zinsmeister AR. Relationship between clinical features and gastric emptying disturbances in diabetes mellitus. Clin Endocrinol 2009; 70: 41520.
  • 12
    Talley NJ, Bytzer P, Hammer J, Young L, Jones M, Horowitz M. Psychological distress is linked to gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2001; 96: 10338.
    Direct Link:
  • 13
    Kong MF, Horowitz M, Jones KL, Wishart JM, Harding PE. Natural history of diabetic gastroparesis. Diabetes Care 1999; 22: 5037.
  • 14
    Wang YR, Fisher RS, Parkman HP. Gastroparesis-related hospitalizations in the United States: trends, characteristics, and outcomes, 1995–2004. Am J Gastroenterol 2008; 103: 31322.
    Direct Link:
  • 15
    Hyett B, Martinez FJ, Gill BM et al. Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis. Gastroenterology 2009; 137: 44552.
  • 16
    Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GNJ. Functional gastroduodenal disorders. Gut 1999; 45(Suppl. II): 3742.
  • 17
    El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 2004; 19: 64354.
  • 18
    Tack J, Talley NJ, Camilleri M et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130: 146679.
  • 19
    Geeraerts B, Tack J. Functional dyspepsia: past, present, and future. J Gastroenterol 2008; 43: 2515.
  • 20
    Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol 2007; 102: 19839.
    Direct Link:
  • 21
    Van Kerkhoven LA, Laheij RJ, Meineche-Schmidt V, Veldhuyzen-van Zanten SJ, De Wit NJ, Jansen JB. Functional dyspepsia: not all roads seem to lead to Rome. J Clin Gastroenterol 2009; 43: 11822.
  • 22
    Aro P, Talley NJ, Storskrubb T et al. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology 2009; 137: 94100.
  • 23
    Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007; 115: 38797.
  • 24
    Jones KL, Horowitz M, Wishart MJ, Maddox AF, Harding PE, Chatterton BE. Relationships between gastric emptying, intragastric meal distribution and blood glucose concentrations in diabetes mellitus. J Nucl Med 1995; 36: 22208.
  • 25
    Rothstein RD. Gastrointestinal motility disorders in diabetes mellitus. Am J Gastroenterol 1990; 85: 7825.
  • 26
    Sanger GJ, Lee K. Hormones of the gut-brain axis as targets for the treatment of upper gastrointestinal disorders. Nat Rev Drug Discov 2008; 7: 24154.
  • 27
    Nematy M, O’Flynn JE, Wandrag L et al. Changes in appetite related gut hormones in intensive care unit patients: a pilot cohort study. Crit Care 2006; 10: R108.
  • 28
    Nguyen NQ, Fraser RJ, Chapman M et al. Fasting and nutrient-stimulated plasma peptide-YY levels are elevated in critical illness and associated with feed intolerance: an observational, controlled study. Crit Care 2006; 10: R17584.
  • 29
    Harsch IA, Koebnick C, Tasi AM, Hahn EG, Konturek PC. Ghrelin and obestatin levels in type 2 diabetic patients with and without delayed gastric emptying. Dig Dis Sci 2009; 54: 21616.
  • 30
    Spiller RC. Role of infection in irritable bowel syndrome. J Gastroenterol 2007; 17: 417.
  • 31
    Mearin F, Perez-Oliveras M, Perello A et al. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 2005; 129: 98104.
  • 32
    Hanevik K, Hausken T, Morken MH et al. Persisting symptoms and duodenal inflammation related to Giardia duodenalis infection. J Infect 2007; 55: 52430.
  • 33
    Dizdar V, Gilja OH, Hausken T. Increased visceral sensitivity in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT(3)-antagonist ondansetron. Neurogastroenterol Motil 2007; 19: 97782.
  • 34
    Tack J, Demedts I, Dehondt G et al. Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterology 2002; 122: 173847.
  • 35
    Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003; 98: 7838.
    Direct Link:
  • 36
    Laine L, Schoenfeld P, Fennerty MB. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001; 134: 3619.
  • 37
    Laheij RJ, Van Rossum LG, Verbeek AL, Jansen JB. Helicobacter pylori infection treatment of nonulcer dyspepsia: an analysis of meta-analyses. J Clin Gastroenterol 2003; 36: 31520.
  • 38
    Raghavan S, Holmgren J. CD4+ CD25+ suppressor T cells regulate pathogen induced inflammation and disease. FEMS Immunol Med Microbiol 2005; 44: 1217.
  • 39
    Bardhan PK, Salam MA, Molla AM. Gastric emptying of liquid in children suffering from acute rotaviral gastroenteritis. Gut 1992; 33: 269.
  • 40
    Meeroff JC, Schreiber DS, Trier JS, Blacklow NR. Abnormal gastric motor function in viral gastroenteritis. Ann Intern Med 1980; 92: 3703.
  • 41
    Oh JJ, Kim CH. Gastroparesis after a presumed viral illness: clinical and laboratory features and natural history. Mayo Clin Proc 1990; 65: 63642.
  • 42
    Bityutskiy LP, Soykan I, McCallum RW. Viral gastroparesis: a subgroup of idiopathic gastroparesis – clinical characteristics and long-term outcomes. Am J Gastroenterol 1997; 92: 15014.
  • 43
    Pande H, Lacy BE, Crowell MD. Inflammatory causes of gastroparesis: report of five cases. Dig Dis Sci 2002; 47: 26648.
  • 44
    Talley NJ, Walker MM, Aro P et al. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case–control study. Clin Gastroenterol Hepatol 2007; 5: 117583.
  • 45
    Friesen CA, Lin Z, Singh M et al. Antral inflammatory cells, gastric emptying, and electrogastrography in pediatric functional dyspepsia. Dig Dis Sci 2008; 53: 263440.
  • 46
    Rajan E, Gostout CJ, Lurken MS et al. Endoscopic ‘no hole’ full thickness biopsy of the stomach to detect myenteric ganglia. Gastrointest Endosc 2008; 68: 3017.
  • 47
    Vittal H, Farrugia G, Gomez G, Pasricha PJ. Mechanisms of disease: the pathological basis for gastroparesis – a review of experimental and clinical studies. Nat Clin Prac Gastroenterol Hepatol 2007; 4: 33646.
  • 48
    Takahashi T, Nakamura K, Itoh H, Sima AA, Owyang C. Impaired expression of nitric oxide synthase in the gastric myenteric plexus of spontaneously diabetic rats. Gastroenterology 1997; 113: 153544.
  • 49
    He CL, Soffer EE, Ferris CD, Walsh RM, Szurszewski JH, Farrugia G. Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes. Gastroenterology 2001; 121: 42734.
  • 50
    Iwasaki H, Kajimura M, Osawa S et al. A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus. J Gastroenterol 2006; 41: 107687.
  • 51
    Miller S, Narasimhan R, Schmalz P et al. Distribution of interstitial cells of cajal and nitrergic neurons in normal and diabetic human appendix. Neurogastroenterol Motil 2008; 20: 34957.
  • 52
    Choi KM, Gibbons SJ, Nguyen TV et al. Heme oxygenase-1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis. Gastroenterology 2008; 135: 205564.
  • 53
    Horváth VJ, Vittal H, Lörincz A et al. Reduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesis. Gastroenterology 2006; 130: 75970.
  • 54
    Azpiroz F, Bouin M, Camilleri M et al. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil 2007; 19: 6288.
  • 55
    Camilleri M. Functional dyspepsia: mechanisms of symptom generation and appropriate management of patients. Gastroenterol Clin North Am 2007; 36: 64964.
  • 56
    Karamanolis G, Caenepeel P, Arts J, Tack J. Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology 2006; 130: 296303.
  • 57
    Mayer EA, Aziz Q, Coen S et al. Brain imaging approaches to the study of functional GI disorders: a Rome working team report. Neurogastroenterol Motil 2009; 21: 57996.
  • 58
    Mayer EA, Bradesi S, Chang L, Spiegel BM, Bueller JA, Naliboff BD. Functional GI disorders: from animal models to drug development Gut 2008; 57: 384404.
  • 59
    Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993; 75: 127386.
  • 60
    Gangula PR, Maner WL, Micci MA, Garfield RE, Pasricha PJ Diabetes induces sex-dependent changes in neuronal nitric oxide synthase dimerization and function in the rat gastric antrum. Am J Physiol Gastrointest Liver Physiol 2007; 292: G72533.
  • 61
    Chaudhury A, He XD, Goyal RK. Role of PSD95 in membrane association and catalytic activity of nNOS{alpha} in nitrergic varicosities in mice gut. Am J Physiol Gastrointest Liver Physiol 2009; [Epub ahead of print].
  • 62
    Rao YM, Chaudhury A, Goyal RK. Active and inactive pools of nNOS in the nerve terminals in mouse gut: implications for nitrergic neurotransmission. Am J Physiol Gastrointest Liver Physiol 2008; 294: G62734.
  • 63
    Nakamura K, Takahashi T, Taniuchi M, Hsu CX, Owyang C. Nicotinic receptor mediates nitric oxide synthase expression in the rat gastric myenteric plexus. J Clin Invest 1998; 101: 147989.
  • 64
    Watkins CC, Sawa A, Jaffrey S et al. Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. J Clin Invest 2000; 106: 37384.
  • 65
    Shah V, Lyford G, Gores G, Farrugia G. Nitric oxide in gastrointestinal health and disease. Gastroenterology 2004; 126: 90313.
  • 66
    Horvath VJ, Vittal H, Ordog T. Reduced insulin and IGF-I signaling, not hyperglycemia, underlies the diabetes-associated depletion of interstitial cells of Cajal in the murine stomach. Diabetes 2005; 54: 152833.
  • 67
    James AN, Ryan JP, Crowell MD, Parkman HP. Regional gastric contractility alterations in a diabetic gastroparesis mouse model: effects of cholinergic and serotoninergic stimulation. Am J Physiol Gastrointest Liver Physiol 2004; 287: G6129.
  • 68
    Takahashi T, Kojima Y, Tsunoda Y et al. Impaired intracellular signal transduction in gastric smooth muscle of diabetic BB/W rats. Am J Physiol 1996; 270: G4117.
  • 69
    Choi KM, Gibbons SJ, Roeder JL et al. Regulation of interstitial cells of Cajal in the mouse gastric body by neuronal nitric oxide. Neurogastroenterol Motil 2007; 19: 58595.
  • 70
    Korenaga K, Micci MA, Taglialatela G, Pasricha PJ. Suppression of nNOS expression in rat enteric neurones by the receptor for advanced glycation end-products. Neurogastroenterol Motil 2006; 18: 392400.
  • 71
    Jeyabal PV, Kumar R, Gangula PR, Micci MA, Pasricha PJ. Inhibitors of advanced glycation end-products prevent loss of enteric neuronal nitric oxide synthase in diabetic rats. Neurogastroenterol Motil 2008; 20: 25361.
  • 72
    Gibson TM, Cotter MA, Cameron NE. Effects of alpha-lipoic acid on impaired gastric fundus innervation in diabetic rats. Free Radic Biol Med 2003; 35: 1608.
  • 73
    Liu LS, Winston JH, Shenoy MM, Song GQ, Chen JD, Pasricha PJ. A rat model of chronic gastric sensorimotor dysfunction resulting from transient neonatal gastric irritation. Gastroenterology 2008; 134: 20709.
  • 74
    Jian R, Ducrot F, Ruskone A et al. Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. Dig Dis Sci 1989; 34: 65764.
  • 75
    Galil MA, Critchley M, Mackie CR. Isotope gastric emptying tests in clinical practice: expectation, outcome, and utility. Gut 1993; 34: 9169.
  • 76
    Tougas GH, Eaker EY, Abell TL et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 2000; 95: 145662.
    Direct Link:
  • 77
    Abell TL, Camilleri M, Donohoe K et al. Consensus recommendations for gastric emptying scintigraphy. A joint report of the Society of Nuclear Medicine and The American Neurogastroenterology and Motility Society. Am J Gastroenterology 2008; 103: 75363.
    Direct Link:
  • 78
    Thomforde GM, Camilleri M, Phillips SF, Forstrom LA. Evaluation of an inexpensive screening scintigraphic test of gastric emptying. J Nucl Med 1995; 36: 936.
  • 79
    Guo J-P, Maurer AH, Fisher RS, Parkman HP. Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis. Dig Dis Sci 2001; 46: 249.
  • 80
    Lartigue S, Bizais Y, Des Varannes SB, Murat A, Pouliquen B, Galmiche JP. Inter- and intrasubject variability of solid and liquid gastric emptying parameters. A scintigraphic study in healthy subjects and diabetic patients. Dig Dis Sci 1994; 39: 10915.
  • 81
    Troncon LE, Bennett RJ, Ahluwalia NK, Thompson DG. Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients. Gut 1994; 35: 32732.
  • 82
    Gonlachanvit S, Maurer AH, Fisher RS, Parkman HP. Regional gastric emptying abnormalities in functional dyspepsia and gastroesophageal reflux disease. Neurogastroenterol Motil 2006; 18: 894904.
  • 83
    Piessevaux H, Tack J, Wairand S, Pauwels S, Geubel A. Intragastric distribution of a standardized meal in health and functional dyspepsia: correlation with specific symptoms. Neurogastroenterol Motil 2003; 15: 44755.
  • 84
    Simonian HP, Maurer AH, Knight LC et al. Simultaneous assessment of gastric accommodation and emptying: studies with liquid and solid meals. J Nucl Med 2004; 45: 115560.
  • 85
    Burton DD, Kim HJ, Camilleri M et al. Relationship of gastric emptying and volume changes after a solid meal in humans. Am J Physiol Gastrointest Liver Physiol 2005; 289: G2616.
  • 86
    Kuo B, McCallum RW, Koch K et al. Comparison of gastric emptying of a non-digestible capsule to a radiolabeled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther 2008; 27: 18696.
  • 87
    Cassilly D, Kantor S, Knight L, Maurer A, Fisher RS, Parkman HP. Gastric emptying of a nondigestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy. Neurogastroenterol Motil 2008; 20: 3119.
  • 88
    Rao SS, Kuo B, McCallum RW et al. Investigation of novel wireless motility capsule for colonic and whole gut transit: a comparative study with radioopaque markers in health and constipation. Clin Gastroenterol Hepatol 2009; 7: 53744.
  • 89
    Camilleri M, Bharucha AE, DiLorenzo C et al. American Neurogastroenterology and Motility Society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice. Neurogastroenterol Motil 2008; 20: 126982.
  • 90
    Ghoos YF, Maes BD, Geypens BJ et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 1993; 104: 16407.
  • 91
    Viramontes BE, Kim DY, Camilleri M et al. Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying. Neurogastroenterol Motil 2001; 13: 56774.
  • 92
    Szarka LA, Camilleri M, Vella A et al. A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol 2008; 6: 63543.
  • 93
    Mundt MW, Hausken T, Smout AJ, Samsom M. Relationships between gastric accommodation and gastrointestinal sensations in healthy volunteers. A study using the barostat technique and two- and three-dimensional ultrasonography. Dig Dis Sci 2005; 50: 165460.
  • 94
    Mundt MW, Samsom M. Fundal dysaccommodation in functional dyspepsia: head-to-head comparison between the barostat and three-dimensional ultrasonographic technique. Gut 2006; 55: 172530.
  • 95
    Hveem K, Sun WM, Hebbard GS, Horowitz M, Doran S, Dent J. Relationship between ultrasonically detected phasic antral contractions and antral pressure. Am J Physiol 2001; 281: G95101.
  • 96
    Hausken T, Odegaard S, Matre K, Berstad A. Antroduodenal motility and movements of luminal contents studied by duplex sonography. Gastroenterology 1992; 102: 158390.
  • 97
    Ahmed AB, Gilja OH, Hausken T, Gregersen H, Matre K. Strain measurement during antral contractions by ultrasound strain rate imaging: influence of erythromycin. Neurogastroenterol Motil 2009; 21: 1709.
  • 98
    Hveem K, Jones KL, Chatterton BE, Horowitz M. Scintigraphic measurement of gastric emptying and ultrasonographic assessment of antral area: relation to appetite. Gut 1996; 38: 81621.
  • 99
    Gentilcore D, Hausken T, Horowitz M, Jones KL. Measurements of gastric emptying of low- and high-nutrient liquids using 3D ultrasonography and scintigraphy in healthy subjects. Neurogastroenterol Motil 2006; 18: 10628.
  • 100
    Savoye-Collet C, Savoye G, Smout A. Determinants of transpyloric fluid transport: a study using combined real-time ultrasound, manometry, and impedance recording. Am J Physiol Gastrointest Liver Physiol 2003; 285: G114752.
  • 101
    O’Donovan D, Hausken T, Lei Y et al. Effect of aging on transpyloric flow, gastric emptying, and intragastric distribution in healthy humans – impact on glycemia. Dig Dis Sci 2005; 50: 6716.
  • 102
    Hausken T, Berstad A. Wide gastric antrum in patients with non-ulcer dyspepsia. Effect of cisapride. Scand J Gastroenterol 1992; 27: 42732.
  • 103
    Lunding JA, Tefera S, Gilja OH et al. Rapid initial gastric emptying and hypersensitivity to gastric filling in functional dyspepsia: effects of duodenal lipids. Scand J Gastroenterol 2006; 41: 102836.
  • 104
    Gilja OH, Hausken T, Wilhelmsen I, Berstad A. Impaired accommodation of proximal stomach to a meal in functional dyspepsia. Dig Dis Sci 1996; 41: 68996.
  • 105
    Undeland KA, Hausken T, Svebak S, Aanderud S, Berstad A. Wide gastric antrum and low vagal tone in patients with diabetes mellitus type 1 compared to patients with functional dyspepsia and healthy individuals. Dig Dis Sci 1996; 41: 916.
  • 106
    Undeland KA, Hausken T, Gilja OH, Aanderud S, Berstad A. Gastric meal accommodation studied by ultrasound in diabetes. Relation to vagal tone. Scand J Gastroenterol 1998; 33: 23641.
  • 107
    Hausken T, Søndenaa K, Svebak S et al. Common pathogenetic mechanisms in symptomatic, uncomplicated gallstone disease and functional dyspepsia: volume measurement of gallbladder and antrum using three-dimensional ultrasonography. Dig Dis Sci 1997; 42: 250512.
  • 108
    Van Lelyveld N, Scheffer R, Mundt M, Samsom M. Partial gastric volumes and upper abdominal sensations in functional dyspeptic and GERD patients: a 3D ultrasonographic study. Am J Gastroenterol 2006; 101: 184552.
    Direct Link:
  • 109
    Mansfield P. Multi-planar image formation using NMR spin echoes. J Phys C-Solid State Phys 1977; 10: L558.
  • 110
    Howseman AM, Stehling MK, Chapman B et al. Improvements in snap-shot nuclear magnetic resonance imaging. Br J Radiol 1988; 61: 8228.
  • 111
    Schwizer W, Fraser R, Maecke H, Siebold K, Funck R, Fried M. Gd-DOTA as a gastrointestinal contrast agent for gastric emptying measurements with MRI. Magn Reson Med 1994; 31: 38893.
  • 112
    Schwizer W, Maecke H, Fried M. Measurement of gastric emptying by magnetic resonance imaging in humans. Gastroenterology 1992; 103: 36976.
  • 113
    Feinle C, Kunz P, Boesiger P, Fried M, Schwizer W. Scintigraphic validation of a magnetic resonance imaging method to study gastric emptying of a solid meal in humans. Gut 1999; 44: 10611.
  • 114
    Fidler J, Bharucha AE, Camilleri M et al. Application of magnetic resonance imaging to measure fasting and postprandial volumes in humans. Neurogastroenterol Motil 2009; 21: 4251.
  • 115
    Fruehauf H, Goetze O, Steingoetter A et al. Intersubject and intrasubject variability of gastric volumes in response to isocaloric liquid meals in functional dyspepsia and health. Neurogastroenterol Motil 2007; 19: 55361.
  • 116
    Ajaj W, Goehde SC, Papanikolaou N et al. Real time high resolution magnetic resonance imaging for the assessment of gastric motility disorders. Gut 2004; 53: 125661.
  • 117
    Mundt MW, Hausken T, Samsom M. Effect of intragastric barostat bag on proximal and distal gastric accommodation in response to liquid meal. Am J Physiol Gastrointest Liver Physiol 2002; 283: G6816.
  • 118
    De Zwart IM, Haans JJ, Verbeek P, Eilers PH, De Roos A, Masclee AA. Gastric accommodation and motility are influenced by the barostat device: assessment with magnetic resonance imaging. Am J Physiol Gastrointest Liver Physiol 2007; 292: G20814.
  • 119
    Marciani L, Spiller R, Fearon KC et al. Factors influencing fasting small bowel water content as assessed by MRI: increased by ondansetron and reduced by intubation but unaltered by dietary fibre. Neurogastroenterol Motil 2008; 20(Suppl. 2): 162 (abstract)
  • 120
    Sanders MK. Bezoars: from mystical charms to medical and nutritional management. Pract Gastroenterol 2004; XXVIII: 37.
  • 121
    Whitson BA, Kandaswamy R, Sutherland DER. Diabetic gastroparesis-associated bezoar resolution via ‘cola-lysis’. Clin Transplant 2008; 22: 2424.
  • 122
    Olausson EA, Alpsten M, Larsson A et al. Small particle size of a solid meal increases gastric emptying and late postprandial glycaemic response in diabetic subjects with gastroparesis. Diabetes Res Clin Pract 2008; 80: 2317.
  • 123
    Russell MK, Mueller C. Nutrition screening and assessment. In: GottschlichMM, ed. The A.S.P.E.N. Nutrition Support Core Curriculum – A Case-Base Approach – The Adult Patient. MD: American Society for Parenteral and Enteral Nutrition, Silver Spring, 2007: 168.
  • 124
    Colemont LJ, Camilleri M. Chronic intestinal pseudo-obstruction: diagnosis and treatment. Mayo Clin Proc 1989; 64: 6070.
  • 125
    McCray S, Walker S, Parrish CR. Much ado about refeeding. Pract Gastroenterol 2004; XXVIII: 26.
  • 126
    Gentilcore D, O’Donovan D, Jones KL et al. Nutrition therapy for diabetic gastroparesis. Curr Diab Rep 2003; 3: 41826.
  • 127
    AMS Gastroparesis Task Force, Abell TL, Bernstein RK et al. Treatment of gastroparesis: a multidisciplinary review. Neurogastroenterol Motil 2006; 18: 26383.
  • 128
    Camilleri M. Clinical practice. Diabetic gastroparesis. N Engl J Med 2007; 356: 8209.
  • 129
    Farrell FJ, Keeffe EB. Diabetic gastroparesis. Dig Dis 1995; 13: 291300.
  • 130
    Van Bronswijk H, Dubois EA, Pijl H, Cohen AF. New drugs; exenatide and sitagliptin. Ned Tijdschr Geneeskd 2008; 152: 8769.
  • 131
    McCallum RW, Ricci DA, Rakatansky H et al. A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care 1983; 6: 4637.
  • 132
    Patterson D, Abell T, Rothstein R, Koch K, Barnett J. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol 1999; 94: 12304.
  • 133
    Richards RD, Davenport K, McCallum RW. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol 1993; 88: 2037.
  • 134
    Miller LS, Szych GA, Kantor SB et al. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol 2002; 97: 165360.
    Direct Link:
  • 135
    Lacy BE, Zayat EN, Crowell MD, Schuster MM. Botulinum toxin for the treatment of gastroparesis: a preliminary report. Am J Gastroenterol 2002; 97: 154852.
    Direct Link:
  • 136
    Arts J, Holvoet L, Caenepeel P et al. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther 2007; 26: 12518.
  • 137
    Friedenberg FK, Palit A, Parkman HP, Hanlon A, Nelson D. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterology 2008; 103: 41623.
    Direct Link:
  • 138
    McCallum RW, Cynshi O, Investigative Team. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis – a randomized, multicentre, placebo-controlled study. Aliment Pharmacol Ther 2007; 26: 112130.
  • 139
    McCallum RW, Cynshi O, US Investigative Team. Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi-center, placebo-controlled trial. Aliment Pharmacol Ther 2007; 26: 10716.
  • 140
    Murray CD, Martin NM, Patterson M et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 2005; 54: 16938.
  • 141
    Tack J, Depoortere I, Bisschops R, Verbeke K, Janssens J, Peeters T. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther 2005; 22: 84753.
  • 142
    Bouras EP, Camilleri M, Burton DD, Thomforde G, McKinzie S, Zinsmeister AR. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology 2001; 120: 35460.
  • 143
    De Maeyer JH, Lefebvre RA, Schuurkes JA. 5-HT4 receptor agonists: similar but not the same. Neurogastroenterol Motil 2008; 20: 99112.
  • 144
    Camilleri M, Manini M, McKinzie S et al. Dose-related effects of TD-5108, a selective 5-HT4 receptor agonist with high intrinsic activity, on gastrointestinal (GI) and colonic transit in healthy volunteers. Neurogastroenterol Motil 2008; 20(Suppl. 2): 6.
  • 145
    Smith JA, Beattie DT, Marquess D, Shaw JP, Vickery RG, Humphrey PP. The in vitro pharmacological profile of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity. Naunyn Schmiedebergs Arch Pharmacol 2008; 378: 12537.
  • 146
    Seto K, Sasaki T, Katsunuma K, Kobayashi N, Tanaka K, Tack J. Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats. Neurogastroenterol Motil 2008; 20: 10519.
  • 147
    Pilichiewicz AN, Horowitz M, Russo A et al. Effects of Iberogast on proximal gastric volume, antropyloroduodenal motility and gastric emptying in healthy men. Am J Gastroenterol 2007; 102: 127683.
    Direct Link:
  • 148
    Von Arnim U, Peitz U, Vinson B, Gundermann KJ, Malfertheiner P. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. Am J Gastroenterol 2007; 102: 126875.
    Direct Link:
  • 149
    Braden B, Caspary W, Börner N, Vinson B, Schneider AR. Clinical effects of STW 5 (Iberogast) are not based on acceleration of gastric emptying in patients with functional dyspepsia and gastroparesis. Neurogastroenterol Motil 2009; 21: 6328.
  • 150
    Micci MA, Kahrig KM, Simmons RS, Sarna SK, Espejo-Navarro MR, Pasricha PJ. Neural stem cell transplantation in the stomach rescues gastric function in neuronal nitric oxide synthase-deficient mice. Gastroenterology 2005; 129: 181724.
  • 151
    Hoogerwerf WA, Pasricha PJ, Kalloo AN, Schuster MM. Pain: the overlooked symptom in gastroparesis. Am J Gastroenterol 1999; 94: 102933.
    Direct Link:
  • 152
    Karamanolis G, Caenepeel P, Arts J, Tack J. Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction? Gut 2007; 56: 2936.
  • 153
    Rentz AM, Kahrilas P, Stanghellini V et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res 2004; 13: 173749.
  • 154
    Stanghellini V, Tosetti C, Horowitz M et al. Predictors of gastroparesis in out-patients with secondary and idiopathic upper gastrointestinal symptoms. Dig Liver Dis 2003; 35: 38996.
  • 155
    Braden B, Enghofer M, Schaub M, Usadel KH, Caspary WF, Lembcke B. Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control. Aliment Pharmacol Ther 2002; 16: 13416.
  • 156
    Soykan I, Sarosiek I, McCallum RW. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol 1997; 92: 97680.
  • 157
    Abell T, McCallum R, Hocking M et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003; 125: 4218.
  • 158
    Lin Z, Forster J, Sarosiek I, McCallum RW. Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation. Diabetes Care 2004; 27: 10716.
  • 159
    Brody F, Vaziri K, Saddler A et al. Gastric electrical stimulation for gastroparesis. J Am Coll Surg 2008; 207: 5338.
  • 160
    Tack J, Lee KJ. Pathophysiology and treatment of functional dyspepsia. J Clin Gastroenterol 2005; 39(5 Suppl. 3): S2116.
  • 161
    Saad RJ, Chey WD. Review article: current and emerging therapies for functional dyspepsia. Aliment Pharmacol Ther 2006; 24: 47592.
  • 162
    Camilleri M. Novel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensation. Neurogastroenterol Motil 2008; 20: 9719.
  • 163
    Takahashi T. Acupuncture for functional gastrointestinal disorders. J Gastroenterol 2006; 41: 817.
  • 164
    Chiarioni G, Whitehead WE. The role of biofeedback in the treatment of gastrointestinal disorders. Nat Clin Pract Gastroenterol Hepatol 2008; 5: 37182.
  • 165
    Lefaucher J-P. Use of repetitive transcranial magnetic stimulation in pain relief. Expert Rev Neurother 2008; 8: 799808.
  • 166
    Soffer E, Abell T, Lin Z et al. Review article: gastric electrical stimulation for gastroparesis – physiological foundations, technical aspects and clinical implications. Aliment Pharmacol Ther 2009; 30: 68194.
  • 167
    Familoni BO, Abell TL, Nemoto D, Voeller G, Johnson B. Electrical stimulation at a frequency higher than based rate in canine stomach. Dig Dis Sci 1997; 42: 8927.
  • 168
    Lin Z, Sarosiek I, Forster J, McCallum RW. Symptom responses, long-term outcomes and adverse events beyond 3 years of high-frequency gastric electrical stimulation for gastroparesis. Neurogastroenterol Motil 2006; 20: 46470.
  • 169
    Maranki JL, Lytes V, Meilahn JE et al. Predictive factors for clinical improvement with enterra gastric electric stimulation treatment for refractory gastroparesis. Dig Dis Sci 2008; 53: 20728.
  • 170
    McCallum R, Brody FJ, Parkman HP et al. Enterra gastric electrical stimulation for diabetic gastroparesis: results from a multicenter randomized study. Gastroenterology 2009; 136: A612.
  • 171
    Sarosiek I, Forster J, Lin Z, McMillin K, Roeser K, McCallum RW. Effect of multi-point gastric electrical pacing (MGP) on symptoms, gastric emptying and electrical activity in diabetic gastroparesis. Gastroenterology 2009; 136: A231 (abstract).
  • 172
    Abell TL, Runnels M, Thompson RW, Weeks ES, Minocha A. A double-blind, randomized, placebo-controlled study of temporary endoscopic mucosal gastric electrical stimulation in gastroparesis: the EndoStim study. (AGA abstract, 2006).
  • 173
    Ayinala S, Batista O, Goyal A et al. Temporary gastric electrical stimulation with orally or PEG-placed electrodes in patients with drug refractory gastroparesis. Gastrointest Endosc 2005; 61: 45561.
  • 174
    Siddaiah N, Johnson WD, Weeks W et al. PIES in gastroparesis: predictors of improvement after electrical stimulation. Gastroenterology 2009; 136: A468 (abstract).
  • 175
    Revicki DA, Rentz AM, Dubois D et al. Gastroparesis cardinal symptom index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res 2004; 13: 83344.
  • 176
    Revicki DA, Rentz AM, Dubois D et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: the gastroparesis cardinal symptom index. Aliment Pharmacol Ther 2003; 18: 14150.
  • 177
    Revicki DA, Camilleri M, Kuo B et al. Development and content validity of a gastroparesis cardinal symptom index daily diary. Aliment Pharmacol Ther 2009; 30: 67080.
  • 178
    Ordog T, Takayama I, Cheung WK, Ward SM, Sanders KM. Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes 2000; 49: 17319.
  • 179
    Ordog T. Interstitial cells of Cajal in diabetic gastroenteropathy. Neurogastroenterol Motil 2008; 20: 818.
  • 180
    Chandrasekharan B, Srinivasan S. Diabetes and the enteric nervous system. Neurogastroenterol Motil 2007; 19: 95160.
  • 181
    Pasricha PJ, Pehlivanov ND, Gomez G, Vittal H, Lurken MS, Farrugia G. Changes in the gastric enteric nervous system and muscle: a case report on two patients with diabetic gastroparesis. BMC Gastroenterol 2008; 8: 21.
  • 182
    Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 2008; 132: 56782.
  • 183
    Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair – current views. Stem Cells 2007; 25: 2896902.
  • 184
    Daley GQ, Scadden DT. Prospects for stem cell-based therapy. Cell 2008; 132: 5448.
  • 185
    Lorincz A, Redelman D, Horvath VJ, Bardsley MR, Chen H, Ordog T. Progenitors of interstitial cells of Cajal in the postnatal murine stomach. Gastroenterology 2008; 134: 108393.
  • 186
    Kruger GM, Mosher JT, Bixby S, Joseph N, Iwashita T, Morrison SJ. Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness. Neuron 2002; 35: 65769.
  • 187
    Micci MA, Kahrig KM, Simmons RS, Sarna SK, Espejo-Navarro MR, Pasricha PJ. Neural stem cell transplantation in the stomach rescues gastric function in neuronal nitric oxide synthase-deficient mice. Gastroenterology 2005; 129: 181724.
  • 188
    Takaki M, Nakayama S, Misawa H, Nakagawa T, Kuniyasu H. In vitro formation of enteric neural network structure in a gut-like organ differentiated from mouse embryonic stem cells. Stem Cells 2006; 24: 141422.